Preparation based on an antibody directed against a tumor-associated glycosylation such as Lewis structures

Details for Australian Patent Application No. 2010203050 (hide)

International Classifications

Event Publications

5 August 2010 Complete Application Filed

12 August 2010 Application Open to Public Inspection

Published as AU-B-2010203050

16 September 2010 Assignment before Grant

Igeneon Krebs-Immuntherapie Forschungs-und Entwicklungs-AG The application has been assigned to Meridian Biopharmaceuticals GmbH; Vela Pharmazeutische Entwicklung und Laboranalytik GmbH; greenovation Biotech GmbH

10 March 2011 Corrigenda

Assignments Before Grant, Section 113 - 2010 Under the name greenovation Biotech GmbH, Application No. 2010203050, under INID (71), correct the coapplicant to Greenovation Biotech GmbH

15 September 2011 Assignment before Grant

Vela Pharmazeutische Entwicklung und Laboranalytik GmbH; Greenovation Biotech GmbH; Meridian Biopharmaceuticals GmbH The application has been assigned to Greenovation Biotech GmbH; Meridian Biopharmaceuticals GmbH

7 June 2012 Application Accepted

Published as AU-B-2010203050

19 July 2012 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 27 Jun 2012 . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.